WHO Grants Emergency Use Listing to India’s Corbevax COVID-19 Vaccine

WHO Grants Emergency Use Listing to India's Corbevax COVID-19 Vaccine

VoM News Desk | January 16, 2024 | 09:35 PM IST | Breaking News, Health, World | Follow on Google News

WHO Grants Emergency Use Listing to India’s Corbevax COVID-19 Vaccine

WHO Grants Emergency Use Listing to India’s Corbevax COVID-19 Vaccine

The World Health Organization (WHO) has granted Emergency Use Listing (EUL) to Corbevax, India’s COVID-19 vaccine manufactured by Biological E Limited. Corbevax, based on a protein sub-unit platform, has already received approval from India’s Drugs Controller General for restricted emergency use in adults, adolescents, and young children. It was also approved as India’s first heterologous COVID-19 booster shot for adults aged 18 and above. The WHO’s EUL for Corbevax is expected to enhance global efforts against COVID-19, and Biological E Ltd expressed confidence in continuing vaccine development to address public health needs.

VoM News Desk

VoM News is an online web portal in jammu Kashmir offers regional, National & global news.